NCT00617539View on ClinicalTrials.gov

Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2014

Conditions
Breast CancerMetastatic Cancer
Interventions
DRUG

irinotecan hydrochloride

DRUG

temozolomide

Trial Locations (1)

94115

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER

NCT00617539 - Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases | Biotech Hunter | Biotech Hunter